Results 151 to 160 of about 19,118,362 (293)

Immunoglobulin E levels and pregnancy-induced hypertension: Japan Environment and Children’s Study [PDF]

open access: gold, 2021
Hyo Kyozuka   +29 more
openalex   +1 more source

Single‐Step Conversion of Metal Impurities in CNTs to Electroactive Metallic Nitride Nanoclusters for Electrochemical CO2 Reduction

open access: yesAdvanced Functional Materials, EarlyView.
A single‐step, low‐temperature co‐pyrolysis process removes encapsulated seed metal NPs (10–50 nm) from CNTs, redistributing them as surface‐anchored metal and metal–nitride NCs (1–1.5 nm). Herein, Ni3N NCs achieve an ultra‐low onset overpotential for CO2 reduction to CO with >98% Faradaic efficiency across 100–700 mA cm−2.
Ahmed Badreldin   +15 more
wiley   +1 more source

Trajectories of class–switching‐related egg and cow's milk allergen‐specific immunoglobulin isotype formation and its modification by eczema with low‐ and high‐affinity immunoglobulin E during early infancy [PDF]

open access: gold, 2019
Makoto Irahara   +11 more
openalex   +1 more source

The Role of Phadiatop Test and Total Immunoglobulin E in Screening Aeroallergens: A Hospital-based Cohort Study  [PDF]

open access: green, 2020
Yun-Chen Chang   +5 more
openalex   +1 more source

Immunoglobulin E, what is it good for?

open access: yesAnnals of Allergy, Asthma & Immunology, 2016
B. T. Kelly, M. Grayson
semanticscholar   +1 more source

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

open access: yesAdvanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang   +9 more
wiley   +1 more source

Immunoglobulin E and allergy.

open access: yesEquine Veterinary Journal, 2016
Bettina Wagner
semanticscholar   +1 more source

Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1

open access: yesAdvanced Functional Materials, EarlyView.
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy